+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Body Contouring Market by Treatment Type, Technology, End-User, Application, Product Type - Global Forecast 2025-2030- Product Image
Body Contouring Market by Treatment Type, Technology, End-User, Application, Product Type - Global Forecast 2025-2030- Product Image
Sale

Body Contouring Market by Treatment Type, Technology, End-User, Application, Product Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011018
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Body Contouring Market grew from USD 354.37 million in 2023 to USD 387.48 million in 2024. It is expected to continue growing at a CAGR of 11.62%, reaching USD 765.34 million by 2030.

Body contouring refers to medical or non-surgical procedures aimed at reshaping and improving the appearance of the body by eliminating excess skin and fat. Its necessity arises from increasing consumer demand for aesthetic enhancement and post-weight loss treatments. The primary applications include improving body contours, reducing cellulite, and achieving targeted fat reduction, often utilized by individuals post-bariatric surgery, childbirth, or extreme weight loss. End-users predominantly consist of dermatology clinics, hospitals, and specialized cosmetic centers. The market for body contouring is propelled by factors such as rising obesity rates, increasing disposable income, advances in technology like cryolipolysis and ultrasound, and growing awareness of body positivity and aesthetic solutions. Recent trends demonstrate a shift towards minimally invasive procedures, fueled by consumer preference for treatments with lower downtime. Opportunities lie in the development of more effective, affordable, and shorter recovery period solutions, along with emerging markets opening up due to broader societal acceptance of cosmetic procedures. However, challenges such as the high cost of procedures, stringent regulatory frameworks, potential side effects, and lack of insurance coverage hamper market growth. Innovations in this market should focus on enhancing the efficacy and safety of non-invasive technologies, creating combination therapies that offer holistic results, and leveraging artificial intelligence for personalized treatment plans. Research into biodegradable materials for safer implant options or advancements in laser technology for skin tightening could provide competitive advantages. The market is gradually evolving from a niche to a mass market, driven by social media influence and the trend of self-care. For robust business growth, companies should concentrate on R&D for safer and more cost-efficient technologies, expanding affordability, and increasing consumer education on available options' safety and efficacy.

Understanding Market Dynamics in the Body Contouring Market

The Body Contouring Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Expanding medical tourism industry driving demand for affordable body contouring services
    • Higher incidence of obesity and related conditions leading to increased interest in body contouring
    • Influence of social media and celebrity endorsements promoting body contouring treatments
    • Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
  • Market Restraints
    • Limited awareness and knowledge about body contouring procedures among potential patients
    • Potential health risks associated with body contouring procedures affecting patient confidence
  • Market Opportunities
    • Emerging market for body contouring procedures in developing countries due to higher adoption rates
    • Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
    • Rising awareness and acceptance of body contouring procedures among men creating new market segments
  • Market Challenges
    • Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
    • High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures

Exploring Porter’s Five Forces for the Body Contouring Market

Porter’s Five Forces framework further strengthens the insights of the Body Contouring Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Body Contouring Market

External macro-environmental factors deeply influence the performance of the Body Contouring Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Body Contouring Market

The Body Contouring Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Body Contouring Market

The Body Contouring Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Body Contouring Market

The Body Contouring Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Body Contouring Market, highlighting leading vendors and their innovative profiles. These include Aerolase, Allergan, Alma Lasers, BTL Aesthetics, Cutera, Cynosure, EndyMed, Fotona, Galderma, Hologic, InMode, Lumenis, Merz Pharma, Sciton, Solta Medical, Syneron Medical, ThermiGen, Valeant Pharmaceuticals, Venus Concept, and Zimmer Aesthetics.

Market Segmentation & Coverage

This research report categorizes the Body Contouring Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment Type
    • Invasive
      • Lower Body Lift
      • Traditional Liposuction
      • Tummy Tuck
    • Minimally Invasive
      • Laser-Assisted Liposuction
      • Radiofrequency-Assisted Liposuction
    • Non-Invasive
      • Cryolipolysis
      • High-Intensity Focused Ultrasound (HIFU)
      • Laser Lipolysis
      • Radiofrequency
  • Technology
    • Cryolipolysis
    • Injectables
    • Laser
    • Radiofrequency
    • Ultrasound
  • End-User
    • Hospitals
    • Medical Spas
    • Specialty Clinics
  • Application
    • Abdomen
    • Arms
    • Body & Back
    • Buttocks
    • Thighs
  • Product Type
    • Consumables
    • Devices
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding medical tourism industry driving demand for affordable body contouring services
5.1.1.2. Higher incidence of obesity and related conditions leading to increased interest in body contouring
5.1.1.3. Influence of social media and celebrity endorsements promoting body contouring treatments
5.1.1.4. Development of innovative body contouring treatments with minimal downtime ensuring quick recovery
5.1.2. Restraints
5.1.2.1. Limited awareness and knowledge about body contouring procedures among potential patients
5.1.2.2. Potential health risks associated with body contouring procedures affecting patient confidence
5.1.3. Opportunities
5.1.3.1. Emerging market for body contouring procedures in developing countries due to higher adoption rates
5.1.3.2. Strategic partnerships and acquisitions among key players leading to enhanced market share and growth
5.1.3.3. Rising awareness and acceptance of body contouring procedures among men creating new market segments
5.1.4. Challenges
5.1.4.1. Rising competition from non-invasive fat reduction treatments like cryolipolysis, ultrasound, and laser therapy impacting market share
5.1.4.2. High treatment costs and lack of insurance coverage discouraging patients from opting for body contouring procedures
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Body Contouring Market, by Treatment Type
6.1. Introduction
6.2. Invasive
6.2.1. Lower Body Lift
6.2.2. Traditional Liposuction
6.2.3. Tummy Tuck
6.3. Minimally Invasive
6.3.1. Laser-Assisted Liposuction
6.3.2. Radiofrequency-Assisted Liposuction
6.4. Non-Invasive
6.4.1. Cryolipolysis
6.4.2. High-Intensity Focused Ultrasound (HIFU)
6.4.3. Laser Lipolysis
6.4.4. Radiofrequency
7. Body Contouring Market, by Technology
7.1. Introduction
7.2. Cryolipolysis
7.3. Injectables
7.4. Laser
7.5. Radiofrequency
7.6. Ultrasound
8. Body Contouring Market, by End-User
8.1. Introduction
8.2. Hospitals
8.3. Medical Spas
8.4. Specialty Clinics
9. Body Contouring Market, by Application
9.1. Introduction
9.2. Abdomen
9.3. Arms
9.4. Body & Back
9.5. Buttocks
9.6. Thighs
10. Body Contouring Market, by Product Type
10.1. Introduction
10.2. Consumables
10.3. Devices
11. Americas Body Contouring Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Body Contouring Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Body Contouring Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BODY CONTOURING MARKET RESEARCH PROCESS
FIGURE 2. BODY CONTOURING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. BODY CONTOURING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. BODY CONTOURING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BODY CONTOURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BODY CONTOURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BODY CONTOURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BODY CONTOURING MARKET DYNAMICS
TABLE 7. GLOBAL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BODY CONTOURING MARKET SIZE, BY LOWER BODY LIFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BODY CONTOURING MARKET SIZE, BY TRADITIONAL LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BODY CONTOURING MARKET SIZE, BY TUMMY TUCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY-ASSISTED LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BODY CONTOURING MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER LIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BODY CONTOURING MARKET SIZE, BY CRYOLIPOLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BODY CONTOURING MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BODY CONTOURING MARKET SIZE, BY LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BODY CONTOURING MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BODY CONTOURING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BODY CONTOURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BODY CONTOURING MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BODY CONTOURING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BODY CONTOURING MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BODY CONTOURING MARKET SIZE, BY ARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BODY CONTOURING MARKET SIZE, BY BODY & BACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BODY CONTOURING MARKET SIZE, BY BUTTOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BODY CONTOURING MARKET SIZE, BY THIGHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BODY CONTOURING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BODY CONTOURING MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 69. CANADA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 70. CANADA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 71. CANADA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. CANADA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BODY CONTOURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CHINA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. CHINA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 111. CHINA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 112. CHINA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 113. CHINA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. CHINA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. CHINA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. CHINA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. INDIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 119. INDIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 120. INDIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 121. INDIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. INDIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. INDIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. INDIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. JAPAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 135. JAPAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 136. JAPAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 137. JAPAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. JAPAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. JAPAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. JAPAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. THAILAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. THAILAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 183. THAILAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 184. THAILAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 185. THAILAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. THAILAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. THAILAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. THAILAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 206. DENMARK BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. DENMARK BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. DENMARK BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. FINLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 233. FRANCE BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 234. FRANCE BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. FRANCE BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. FRANCE BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. FRANCE BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 240. GERMANY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 241. GERMANY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 242. GERMANY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. GERMANY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. GERMANY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. GERMANY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. ITALY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 256. ITALY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 257. ITALY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 258. ITALY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. ITALY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. ITALY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. ITALY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. NORWAY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. NORWAY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. NORWAY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. POLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 288. POLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 289. POLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 290. POLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. POLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. POLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. POLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 295. QATAR BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 296. QATAR BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 297. QATAR BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 298. QATAR BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. QATAR BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. QATAR BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. QATAR BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. SPAIN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 327. SPAIN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 328. SPAIN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 329. SPAIN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 330. SPAIN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 331. SPAIN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 332. SPAIN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. SPAIN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 350. TURKEY BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 351. TURKEY BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 352. TURKEY BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 353. TURKEY BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 354. TURKEY BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 355. TURKEY BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 356. TURKEY BODY CONTOURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 357. TURKEY BODY CONTOURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY INVASIVE, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY NON-INVASIVE, 2018-2030 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES BODY CONTOURING MARKET SIZE, BY APPLICATION

Companies Mentioned

The leading players in the Body Contouring market, which are profiled in this report, include:
  • Aerolase
  • Allergan
  • Alma Lasers
  • BTL Aesthetics
  • Cutera
  • Cynosure
  • EndyMed
  • Fotona
  • Galderma
  • Hologic
  • InMode
  • Lumenis
  • Merz Pharma
  • Sciton
  • Solta Medical
  • Syneron Medical
  • ThermiGen
  • Valeant Pharmaceuticals
  • Venus Concept
  • Zimmer Aesthetics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 387.48 Million
Forecasted Market Value ( USD ) by 2030 $ 765.34 Million
Compound Annual Growth Rate11.6%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Body Contouring Treatments Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), and End user - Global Forecast to 2029 - Product Image

Body Contouring Treatments Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), and End user - Global Forecast to 2029

  • Report
  • 262 Pages
  • Global
From
Body Contouring Market Report by Invasiveness (Non-Invasive Contouring, Minimally Invasive Contouring, Invasive Contouring), End Use (Clinical Research Organizations, Hospitals, Medical Spas, Clinics), and Region 2024-2032 - Product Image

Body Contouring Market Report by Invasiveness (Non-Invasive Contouring, Minimally Invasive Contouring, Invasive Contouring), End Use (Clinical Research Organizations, Hospitals, Medical Spas, Clinics), and Region 2024-2032

  • Report
  • 139 Pages
  • Global
From
Medical Aesthetics Market by Offering, Treatment Types, Operation, End-User - Global Forecast 2025-2030 - Product Image

Medical Aesthetics Market by Offering, Treatment Types, Operation, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Aesthetic Medicine Market by Products, Type, Gender, End-User - Global Forecast 2025-2030 - Product Image

Aesthetic Medicine Market by Products, Type, Gender, End-User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Medical Aesthetic Devices - Global Strategic Business Report - Product Image

Medical Aesthetic Devices - Global Strategic Business Report

  • Report
  • 211 Pages
  • Global
From

About the Body Contouring Market

Body contouring is a type of surgical procedure that reshapes and improves the appearance of the body. It is often used to remove excess fat and skin, and to improve the shape of the body. Common body contouring procedures include liposuction, tummy tuck, breast lift, and arm lift. These procedures can be used to improve the appearance of the body, as well as to improve the patient's self-confidence. Body contouring is a popular procedure among both men and women. It can be used to improve the appearance of the body after significant weight loss, or to improve the shape of the body after pregnancy. It can also be used to improve the appearance of the body after aging. There are many companies in the body contouring market. These include Allergan, Merz Aesthetics, Galderma, and Syneron Candela. These companies offer a variety of body contouring procedures, including liposuction, tummy tuck, breast lift, and arm lift. They also offer a variety of products and services to help patients achieve their desired results. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.